Clinical applications of PET amyloid imaging: an update

[1] Villemagne VL(2008)The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias Mol Neurobiol 38 1-15

[2] Fodero-Tavoletti MT(2009)Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia Arch Gen Psychiatry 66 81-87

[3] Pike KE(2008)Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging Neuroimage 43 430-439

[4] Cappai R(2008)PET imaging of amyloid deposition in patients with mild cognitive impairment Neurobiol Aging 29 1456-1465

[5] Masters CL(2008)Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 1509-1517

[6] Rowe CC(2008)11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain 131 665-680

[7] Small GW(2008)In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain J Neurochem 105 1428-1437

[8] Siddarth P(2008)Imaging amyloid deposition in Lewy body diseases Neurology 71 903-910

[9] Burggren AC(2008)Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography J Neurol Neurosurg Psychiatry 79 1331-1338

[10] Kepe V(2009)Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics Neurobiol Dis 34 107-112

[1] Villemagne VL(2008)The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias Mol Neurobiol 38 1-15

[2] Fodero-Tavoletti MT(2009)Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia Arch Gen Psychiatry 66 81-87

[3] Pike KE(2008)Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging Neuroimage 43 430-439

[4] Cappai R(2008)PET imaging of amyloid deposition in patients with mild cognitive impairment Neurobiol Aging 29 1456-1465

[5] Masters CL(2008)Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 1509-1517

[6] Rowe CC(2008)11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain 131 665-680

[7] Small GW(2008)In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain J Neurochem 105 1428-1437

[8] Siddarth P(2008)Imaging amyloid deposition in Lewy body diseases Neurology 71 903-910

[9] Burggren AC(2008)Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography J Neurol Neurosurg Psychiatry 79 1331-1338

[10] Kepe V(2009)Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics Neurobiol Dis 34 107-112